Earlier systems from other vendors only utilized the ECG signal to assess OSA. Combined analysis of ECG and SpO2 yields better correlation with simultaneously collected, full PSG study data. HST method yields more accurate results with a reduced "white coat effect" by sleeping at home rather than in an unfamiliar, lab environment.

In the many preliminary studies that compared the diagnostic accuracy for OSA using simultaneously collected data from full PSG studies to data collected with OxyHolter and analyzed with LX® Sleep, results showed from 90 - 100% specificity / sensitivity.

Full PSG (sleep lab) studies require enormous facility, staff and equipment resources. Compare that with the simplicity of an at-home study with a single unit recorder for ECG, SpO2 and derived respiratory signals. For detecting OSA, which accounts for the overwhelming percentage of sleep studies, LX Sleep is the economical alternative.

Data intervals called epochs are defined. Direct measurements on the ECG signals are made and EDR (ECG-Derived Respiratory) signals are developed. Pattern recognition and a set of age-dependent classifiers are used to develop the AHI.

Sleep labs can be filled with higher reimbursement, CPAP titration procedures rather than preliminary OSA detection procedures.

Detection is the first step. After that, your medical professional can recommend any of a variety of remedies – from passive sleep aids, to CPAP arrangements, and perhaps corrective surgery.

Add LX®Sleep to Holter LX®Analysis for the best in graphical display and report generation of ECG, SpO2, AHI and a number of other parameters.

Includes Hotline support and software updates during the Warranty

period. eMSA (extended Maintenance and Service Agreement)